Stockwell Lynn
CEO and Exe. Chair of Board
SaleAlert
- Shares
- 7,966,667
- Price
- —
- Value
- —
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•12 filings
DMII
Drugs Made In America Acquisition II Corp.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
6
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get DMII insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
DMII overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
12
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
0
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- J
- Shares
- 100,000
- Price
- —
- Footnotes
- 1
As of the Transaction Date, the reporting person acquired 100,000 ordinary shares from Drugs Made In America Acquisition II LLC, the Issuer's sponsor, for no consideration.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Stockwell Lynn
CEO and Exe. Chair of Board
PurchaseAlert
- Shares
- 700,000
- Price
- —
- Value
- —
Stockwell Lynn
CEO and Exe. Chair of Board
PurchaseAlert
- Shares
- 700,000
- Price
- —
- Value
- —
Drugs Made In America Acquisition II LLC
10% owner
SaleAlert
- Shares
- 7,966,667
- Price
- —
- Value
- —
Drugs Made In America Acquisition II LLC
10% owner
PurchaseAlert
- Shares
- 700,000
- Price
- —
- Value
- —
Drugs Made In America Acquisition II LLC
10% owner
PurchaseAlert
- Shares
- 700,000
- Price
- —
- Value
- —
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | Stockwell Lynn CEO and Exe. Chair of Board | Sale | 7,966,667 | — | — | |
| Sep 26, 2025 | Stockwell Lynn CEO and Exe. Chair of Board | Purchase | 700,000 | — | — | |
| Sep 26, 2025 | Stockwell Lynn CEO and Exe. Chair of Board | Purchase | 700,000 | — | — | |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Sale | 7,966,667 | — | — | |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Purchase | 700,000 | — | — | |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Purchase | 700,000 | — | — |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.